Page last updated: 2024-08-26

nimbolide and Cancer of Prostate

nimbolide has been researched along with Cancer of Prostate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Dawood, M; Efferth, T; Huang, Q; Mahmoud, N; Ng, JPL; Ren, F; Wong, VKW1
Ahn, KS; Alharbi, SA; Chinnathambi, A; Deivasigamani, A; Hui, KM; Jung, YY; Mohan, CD; Rangappa, KS; Sethi, G; Zhang, J1
Arunakaran, J; Arunkumar, R; Brindha Mercy, A; Elumalai, P; Raja Singh, P; Senthilkumar, K; Sharmila, G; Sivakamasundari, V; Suganthapriya, E1
Ahn, KS; Arfuso, F; Deivasigamanim, A; Goh, BC; Hui, KM; Kim, C; Kumar, AP; Lim, LH; Samym, RP; Sethi, G; Shanmugam, MK; Siveen, KS; Wang, L; Zhang, J1
Arunakaran, J; Arunkumar, R; Balakrishnan, S; Priya, ES; Rajalakshmi, M; Sharmila, G; Singh, PR1
Arunakaran, J; Arunkumar, R; Balakrishnan, S; Raja Singh, P; Rajalakshmi, M; Sharmila, G; Sugantha Priya, E1

Other Studies

6 other study(ies) available for nimbolide and Cancer of Prostate

ArticleYear
Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis and suppresses B-RAF/p.ERK-mediated in vivo tumor growth.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 94

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Limonins; Male; Mice; Microtubules; Prostatic Neoplasms

2022
Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models.
    Biochimica et biophysica acta. Molecular cell research, 2022, Volume: 1869, Issue:12

    Topics: Cell Line, Tumor; DNA; Docetaxel; Humans; Limonins; Male; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin

2022
Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
    Cell biochemistry and function, 2014, Volume: 32, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Limonins; Male; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptor, IGF Type 1; Signal Transduction; Somatomedins

2014
Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
    Antioxidants & redox signaling, 2016, Apr-10, Volume: 24, Issue:11

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Limonins; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor

2016
Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84

    Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Limonins; Male; MAP Kinase Signaling System; Molecular Docking Simulation; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha

2016
Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
    Molecular and cellular biochemistry, 2017, Volume: 427, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Limonins; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction

2017